David T. Feinberg - Mar 28, 2024 Form 4 Insider Report for HUMANA INC (HUM)

Role
Director
Signature
David T. Feinberg
Stock symbol
HUM
Transactions as of
Mar 28, 2024
Transactions value $
$17,769
Form type
4
Date filed
4/1/2024, 11:45 AM
Previous filing
Jan 3, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HUM Humana Common 441 Mar 28, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUM Restricted Stock Units Award $17.8K +51 +36.17% $348.41 192 Mar 28, 2024 Humana Common 51 Direct F2
holding HUM Restricted Stock Units 380 Mar 28, 2024 Humana Common 380 Direct F1
holding HUM Restricted Stock Units 3 Mar 28, 2024 Humana Common 3 Direct F3
holding HUM Restricted Stock Units 430 Mar 28, 2024 Humana Common 430 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual Director's fee payable in stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.
F2 Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.
F3 Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
F4 Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under Company's 2019 Amended & Restated Plan.100% of the award is vesting on 12/31/24.